Aikium
Pre-clinicalNearly half of the human proteome remains inaccessible for traditional drug discovery, largely due to intrinsically disordered regions and the limitations of current protein structure models, which are trained on just a fraction of available data.
Founded
2020
Focus
AI / Machine LearningDrug Delivery
About
Nearly half of the human proteome remains inaccessible for traditional drug discovery, largely due to intrinsically disordered regions and the limitations of current protein structure models, which are trained on just a fraction of available data.
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile